Labcorp Holdings (LH) Notes Payables (2009 - 2024)

Labcorp Holdings has disclosed Notes Payables across 8 years of filings, most recently posting $1.4 billion for Q3 2024.

• Notes Payables for Q3 2024 came in at $1.4 billion, up 41.26% year-over-year; the trailing twelve-month figure through Sep 2024 was $1.4 billion (up 41.26% YoY), and the FY2023 annual result was $999.8 million, up 231.83% from the prior year.
• Notes Payables came in at $1.4 billion for Q3 2024 at Labcorp Holdings, down from $2.0 billion in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $2.0 billion in Q1 2024 to a low of $1.5 million in Q4 2021.
• The 5-year median for Notes Payables is $301.4 million (2023), against an average of $577.7 million.
• Across the five-year window, Notes Payables plunged 99.68% in 2022 and surged 58194.12% in 2023, its largest moves.
• Labcorp Holdings' Notes Payables stood at $376.7 million in 2020, then sank by 99.6% to $1.5 million in 2021, then surged by 19986.67% to $301.3 million in 2022, then jumped by 231.83% to $999.8 million in 2023, then surged by 40.02% to $1.4 billion in 2024.
• The last three Notes Payables figures came in at $1.4 billion (Q3 2024), $2.0 billion (Q2 2024), and $2.0 billion (Q1 2024), per Business Quant data.